A Case of Effective Treatment of a Patient with PCDH 19- Related Epilepsy using Corticosteroid
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
An uncommon female-limited intractable epilepsy, protocadherin (PCDH) 19-related epilepsy, is characterized by mutations in the PCDH 19 gene, located on chromosome X. Clinical symptoms include early onset, fever sensitivity, focal seizures and psychomotor retardation. PCDH 19–related epilepsy is unresponsive to conventional antiepileptic drugs (AEDs), but corticosteroid is reported to be effective in a few cases. We report a case of a 25-month-old girl who was admitted to our hospital due to developmental regression, accompanied by aggravated seizures with fever. Although several conventional AEDs were administered, the frequency and severity of seizures increased with mild fever, and the symptoms did not improve. Considering possible immune, and inflammatory involvement in seizure generation, the patient was administered corticosteroid treatment during the acute phase. Corticosteroid dramatically improved seizures and her development gradually. The patient was finally diagnosed with PCDH 19–related epilepsy in genomic evaluation. We observed the effect of corticosteroid on intractable epilepsy in patient with PCDH 19 mutation. If a female patient whose seizures are resistant to conventional AEDs or easily provoked by mild fever, has developmental delay or developmental regression, this ma
Abstract
An uncommon female-limited intractable epilepsy, protocadherin (PCDH) 19-related epilepsy, is characterized by mutations in the PCDH 19 gene, located on chromosome X. Clinical symptoms include early onset, fever sensitivity, focal seizures and psychomotor retardation. PCDH 19–related epilepsy is unresponsive to conventional antiepileptic drugs (AEDs), but corticosteroid is reported to be effective in a few cases. We report a case of a 25-month-old girl who was admitted to our hospital due to developmental regression, accompanied by aggravated seizures with fever. Although several conventional AEDs were administered, the frequency and severity of seizures increased with mild fever, and the symptoms did not improve. Considering possible immune, and inflammatory involvement in seizure generation, the patient was administered corticosteroid treatment during the acute phase. Corticosteroid dramatically improved seizures and her development gradually. The patient was finally diagnosed with PCDH 19–related epilepsy in genomic evaluation. We observed the effect of corticosteroid on intractable epilepsy in patient with PCDH 19 mutation. If a female patient whose seizures are resistant to conventional AEDs or easily provoked by mild fever, has developmental delay or developmental regression, this ma
참고문헌 (18)
- Scheffer IE, "Epilepsy and mental retardation limited to females: an under-recognized disorder", Brain, 131, pp.918~927 (2008)[DOI]
- Dibbens LM, "X-linked protocadherin 19 mutations cause female-limited epilepsy and cognitive impairment", Nat Genet, 40, pp.776~781 (2008)[DOI]
- Juberg RC, "A new familial form of convulsive disorder and mental retardation limited to females", J Pediatr, 79, pp.726~732 (1971)[DOI]
- Depienne C, "Sporadic infantile epileptic encephalopathy caused by mutations in PCDH19 resembles Dravet syndrome but mainly affects females", PLoS Genet, 5, pp.e1000381~ (2009)[DOI]
- Marini C, "Protocadherin 19 mutations in girls with infantile-onset epilepsy", Neurology, 75, pp.646~653 (2010)[DOI]
- Jamal SM, "Novel de novo PCDH19 mutations in three unrelated females with epilepsy female restricted mental retardation syndrome", Am J Med Genet A, 152A, pp.2475~2481 (2010)[DOI]
- Christel D, "Mutations and deletions in PCDH 19 account for various familial or isolated epilepsies in females", Mutat, 32, pp.E1959~E1975 (2011)[DOI]
- Higurashi N, "PCDH19-related female-limited epilepsy: further details regarding early clinical features and therapeutic efficacy", Epilepsy Res, 106, pp.191~199 (2013)[DOI]
- Higurashi N, "Immediate suppression of seizure clusters by corticosteroids in PCDH19 female epilepsy", Seizure, 27, pp.1~5 (2015)[DOI]
- Vanhalst K, "delta-Protocadherins: a gene family expressed differentially in the mouse brain", Cell Mol Life Sci, 62, pp.1247~1259 (2005)[DOI]
- Higurashi N, "PCDH19 mutation in Japanese females with epilepsy", Epilepsy Res, 99, pp.28~37 (2012)[DOI]
- Marini C, "Focal seizures with affective symptoms are a major feature of PCDH19 gene-related epilepsy", Epilepsia, 53, pp.2111~2119 (2012)[DOI]
- Daneman R, "The mouse blood-brain barrier transcriptome: a new resource for understanding the development and function of brain endothelial cells", PLoS One, 5, pp.e13741~ (2010)[DOI]
- Gupta R, "Corticosteroids in the management of the paediatric epilepsies", Arch Dis Child, 90, pp.379~384 (2005)[DOI]
- Gomes JA, "Glucocorticoid therapy in neurologic critical care", Crit Care Med, 33, pp.1214~1212 (2005)[DOI]
- Marchi N, "Efficacy of anti-inflammatory therapy in a model of acute seizures and in a population of pediatric drug resistant epileptics", PLoS One, 6, pp.e18200~ (2011)[DOI]
- Foster C, "Glucocorticoid effects on mouse microvascular endothelial barrier permeability are brain specific", J Physiol, 573, pp.413~425 (2006)[DOI]
- Salvador E, "Glucocorticoids and endothelial cell barrier function", Cell Tissue Res, 355, pp.597~605 (2014)[DOI]